Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy

Publication date

2017-10-03

Authors

Maspero, MatteoORCID 0000-0003-0347-3375
Van Den Berg, Cornelis A.T.ORCID 0000-0002-5565-6889
Zijlstra, Frank
Sikkes, Gonda G
de Boer, J C J
Meijer, Gert J.ORCID 0000-0001-7275-319XISNI 0000000389724736
Kerkmeijer, Linda G.W.ISNI 0000000393809169
Viergever, Max A.ORCID 0000-0003-2582-042XISNI 0000000117491940
Lagendijk, Jan J.W.ISNI 0000000393637862
Seevinck, Peter R.ISNI 0000000390489892

Editors

Advisors

Supervisors

Document Type

Article

Collections

License

Abstract

An MR-only radiotherapy planning (RTP) workflow would reduce the cost, radiation exposure and uncertainties introduced by CT-MRI registrations. In the case of prostate treatment, one of the remaining challenges currently holding back the implementation of an RTP workflow is the MR-based localisation of intraprostatic gold fiducial markers (FMs), which is crucial for accurate patient positioning.  Currently, MR-based FM localisation is clinically performed manually. This is sub-optimal, as manual interaction increases the workload. Attempts to perform automatic FM detection often rely on being able to detect signal voids induced by the FMs in magnitude images. However, signal voids may not always be sufficiently specific, hampering accurate and robust automatic FM localisation.  Here, we present an approach that aims at automatic MR-based FM localisation. This method is based on template matching using a library of simulated complex-valued templates, and exploiting the behaviour of the complex MR signal in the vicinity of the FM. Clinical evaluation was performed on seventeen prostate cancer patients undergoing external beam radiotherapy treatment. Automatic MR-based FM localisation was compared to manual MR-based and semi-automatic CT-based localisation (the current gold standard) in terms of detection rate and the spatial accuracy and precision of localisation. The proposed method correctly detected all three FMs in 15/17 patients. The spatial accuracy (mean) and precision (STD) were 0.9 mm and 0.5 mm respectively, which is below the voxel size of 1.1 × 1.1 × 1.2 mm3 and comparable to MR-based manual localisation. FM localisation failed (3/51 FMs) in the presence of bleeding or calcifications in the direct vicinity of the FM.  The method was found to be spatially accurate and precise, which is essential for clinical use. To overcome any missed detection, we envision the use of the proposed method along with verification by an observer. This will result in a semi-automatic workflow facilitating the introduction of an MR-only workflow.

Keywords

fiducial marker localisation, magnetic resonance, MRI simulation, position verification, radiotherapy, template matching, Radiotherapy Dosage, Automation, Fiducial Markers, Radiotherapy Planning, Computer-Assisted/methods, Patient Positioning, Humans, Magnetic Resonance Imaging/methods, Male, Gold/chemistry, Radiotherapy, Image-Guided/methods, Prostatic Neoplasms/metabolism, Radiological and Ultrasound Technology, Radiology Nuclear Medicine and imaging, Journal Article, Evaluation Studies

Citation

Maspero, M, van den Berg, CAT, Zijlstra, F, Sikkes, G G, de Boer, JCJ, Meijer, GJ, Kerkmeijer, LGW, Viergever, MA, Lagendijk, JJW & Seevinck, PR 2017, 'Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy', Physics in Medicine and Biology, vol. 62, no. 20, pp. 7981-8002. https://doi.org/10.1088/1361-6560/aa875f, https://doi.org/10.1088/1361-6560/aa875f, https://doi.org/10.1088/1361-6560/aa875f